Regenerative medicine and stem cell research
Stem cell and regenerative medicine research has the potential to impact on several industry sectors and the global market value is expected to reach nearly $10 billion (£6.5 billion) by 2013.
Scope of clinical research trials in Scotland
Scotland is at the forefront of stem cell research and regenerative medicine based on citation impact:
- 1st in the world for stem cell research
- 4th in the world for clinical medicine research
We’re home to one of Europe’s largest and most highly regarded stem cell research communities offering the ideal collaborative environment for your next project. Recent successes include:
A new partnership between Scottish and Californian universities on stem cell research which could lead to major breakthroughs for people living with life-threatening conditions.
US-based Gallus BioPharmaceuticals, a leading provider of contract services to biopharmaceutical companies, founded by GlobalScot Mark Bamforth has forged an exclusive partnership with Edinburgh's Roslin Cells to supply cell therapies to clients - read the full story.
Academic and clinical strengths
Scotland has commercially attractive academic and clinical strengths, particularly in the area of translational stem cells – the transfer of basic research from ‘bench to bedside’
High profile projects and ongoing trials
Optimise your business success
Scotland gives you access to:
- Globally recognised research community
- Collaborative clinical base
- Growing commercial base
- Highly skilled and flexible workforce
- Supportive regulatory and funding environment
- High-quality and supportive infrastructure
- Streamlined process for clinical trials
Scotland's development strategy
Read the Regenerative Medicine Scotland strategy - "Collaborate, Innovate, Translate" via slideshare.net to learn more about Scotland's vision for the future in this key life sciences sector